Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
183,255,226
-
Number of holders
-
189
-
Total 13F shares, excl. options
-
92,662,760
-
Shares change
-
+1,221,068
-
Total reported value, excl. options
-
$2,264,521,795
-
Value change
-
+$28,820,026
-
Put/Call ratio
-
17%
-
Number of buys
-
104
-
Number of sells
-
-60
-
Price
-
$24.44
Significant Holders of HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) as of Q1 2019
215 filings reported holding HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share as of Q1 2019.
HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) has 189 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 92,662,760 shares
of 183,255,226 outstanding shares and own 51% of the company stock.
Largest 10 shareholders include FRANKLIN RESOURCES INC (8,578,877 shares), FMR LLC (8,473,847 shares), VANGUARD GROUP INC (6,414,507 shares), TANG CAPITAL MANAGEMENT LLC (5,744,096 shares), JANUS HENDERSON GROUP PLC (5,197,675 shares), WELLINGTON MANAGEMENT GROUP LLP (5,144,988 shares), BAKER BROS. ADVISORS LP (5,018,104 shares), BlackRock Inc. (4,858,735 shares), STATE STREET CORP (3,232,627 shares), and ArrowMark Colorado Holdings LLC (2,668,643 shares).
This table shows the top 189 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.